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Background: In the GOLD (Global initiative for chronic Obstructive Lung Disease) strategy 
document, the Clinical COPD Questionnaire (CCQ), COPD Assessment Test (CAT), or modified 
Medical Research Council (mMRC) scale are recommended for the assessment of symptoms using 
the cutoff points of CCQ $1, CAT $10, and mMRC scale $2 to indicate symptomatic patients. 
The current study investigates the criterion validity of the CCQ, CAT and mMRC scale based on 
a reference cutoff point of St George’s Respiratory Questionnaire (SGRQ) $25, as suggested by 
GOLD, following sensitivity and specificity analysis. In addition, areas under the curve (AUCs) of the 
CCQ, CAT, and mMRC scale were compared using two SGRQ cutoff points ($25 and $20).
Materials and methods: Two data sets were used: study A, 238 patients from a pulmonary 
rehabilitation program; and study B, 101 patients from primary care. Receiver-operating char-
acteristic (ROC) curves were used to assess the correspondence between the recommended 
cutoff points of the questionnaires.
Results: Sensitivity, specificity, and AUC scores for cutoff point SGRQ $25 were: study A, 
0.99, 0.43, and 0.96 for CCQ $1, 0.92, 0.48, and 0.89 for CAT $10, and 0.68, 0.91, and 0.91 
for mMRC $2; study B, 0.87, 0.77, and 0.9 for CCQ $1, 0.76, 0.73, and 0.82 for CAT $10, 
and 0.21, 1, and 0.81 for mMRC $2. Sensitivity, specificity, and AUC scores for cutoff point 
SGRQ $20 were: study A, 0.99, 0.73, and 0.99 for CCQ $1, 0.91, 0.73, and 0.94 for CAT $10, 
and 0.66, 0.95, and 0.94 for mMRC $2; study B, 0.8, 0.89, and 0.89 for CCQ $1, 0.69, 0.78, 
and 0.8 for CAT $10, and 0.18, 1, and 0.81 for mMRC $2.
Conclusion: Based on data from these two different samples, this study showed that the sug-
gested cutoff point for the SGRQ ($25) did not seem to correspond well with the established 
cutoff points of the CCQ or CAT scales, resulting in low specificity levels. The correspondence 
with the mMRC scale seemed satisfactory, though not optimal. The SGRQ threshold of $20 
corresponded slightly better than SGRQ $25, recently suggested by GOLD 2015, with the 
established cutoff points for the CCQ, CAT, and mMRC scale.
Keywords: pulmonary disease, chronic obstructive, health status
Introduction
COPD is a prevalent disease worldwide, characterized by persistent airflow limitation.1 
COPD patients suffer for years and die prematurely due to its complications.1,2 
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Patients’ experiences vary independently of airflow limi-
tation, with some able to cope well with daily activities, 
while others are completely handicapped.2 Until 2009, 
GOLD (Global initiative for chronic Obstructive Lung 
Disease) classification of COPD disease severity was based 
on spirometry alone, with no regard for health status or 
dyspnea assessment. Management of the disease was based 
on forced expiratory volume in 1 second (FEV
1
), which 
does not adequately reflect patients’ well-being or disease 
impact.2,3 From 2011 onward, GOLD suggested COPD 
patients be classified into a risk-category system accord-
ing to FEV
1
, number of exacerbations, and health status 
or dyspnea assessment.1,4–6 Health status can be evaluated 
using the COPD Clinical Questionnaire (CCQ)7 and the 
COPD Assessment Test (CAT);8 alternatively, the level 
of dyspnea can be evaluated by using the modified British 
Medical Research Council (mMRC) dyspnea scale.9 Based 
on this classification, patients are grouped into four catego-
ries: A, B, C, and D. This grouping consequently influences 
treatment decisions.1,4–6 If a discrepancy in risk assessment 
exists in this classification system, GOLD recommends 
assignment to the higher-risk category.1,4–6
In the GOLD recommendations, the cutoff points of the 
CCQ, CAT, and mMRC scale have been set to 1, 10, and 2 
points, respectively, while the recent GOLD 2015 update sug-
gests that the CCQ cutoff point could be 1–1.5.1,4–6 However, 
recent publications have shown a limited correspondence 
between these cutoff points, resulting in differences in patient 
classification.10–18
Clinicians and researchers use several health-status ques-
tionnaires. St George’s Respiratory Questionnaire (SGRQ),19 
the CCQ,7 and the CAT8 are the most commonly used. The 
CCQ has been ranked first on the International Primary 
Care Respiratory Group ranking as the most appropriate 
tool for use in primary care.20 In the same tool guide, the 
CAT, mMRC scale, and SGRQ follow after the CCQ in this 
ranking.20 The SGRQ is the most widely used questionnaire 
in clinical trials to assess health status in COPD patients, and 
is considered the gold standard.19 However, the use of the 
SGRQ in daily clinical practice is limited, due to its length, 
difficulty to administer, and complex score-calculation 
process.20 Therefore, the well-validated and more practical 
CCQ and CAT have both been proposed as alternatives by 
GOLD.1,4–6 Many researchers and clinicians still use the 
SGRQ though for the assessment of health status in their 
COPD patients. Until recently, there was no information 
about which cutoff points of the CCQ and CAT should be 
used in relation to the SGRQ reference.
Recently, a cutoff point $25 of the SGRQ has been 
suggested as the gold standard.6 The current study aimed 
to investigate if an SGRQ cutoff point of $25 or another 
cutoff point is (more) appropriate to be used in practice. This 
study aimed also to investigate the criterion validity of the 
CCQ, CAT, and mMRC scale cutoff points in differentiating 
between high- and low-symptom groups using the suggested 
cutoff point of the SGRQ as the gold standard, based on 
sensitivity and specificity analyses.
Materials and methods
Patients
Data from patients from two different studies were used. 
In study A, participants were recruited from Clinic Bad 
Reichenhall, Center for Rehabilitation, Pulmonology, and 
Orthopedics in Germany between February and November 
2013. During this period, 238 patients were enrolled from 
an ongoing clinical trial conducted to evaluate the effec-
tiveness of a 3-week pulmonary rehabilitation program 
on health status, psychological well-being, and physi-
ological status. Participants with spirometry-confirmed 
COPD GOLD category II–IV were included. Patients with 
a relevant hypercapnic respiratory failure (CO
2
 partial 
pressure $50 mmHg in rest or indication for noninvasive 
breathing), linguistic and cognitive limitations, and lack of 
motivation were excluded. The study was approved by the 
Ethik-Kommission der Bayerischen Landesärztekammer 
(12107) and registered in the German Clinical Trial 
Register (DRKS00004609). All participants gave written 
informed consent. For this analysis, only prerehabilita-
tion measurements of the CCQ, CAT, mMRC scale, and 
SGRQ were used.
In study B, 101 patients, recruited mainly from primary 
care, participated in a three-visit observational study assessing 
the relationship and responsiveness of four patient-reported 
outcomes: the CCQ, CAT, SGRQ, and mMRC scale. Patients 
45 years of age and older with a smoking history of at least 
10 years were included. Exclusion criteria were patients with 
concomitant asthma, unstable cardiovascular disease, or any 
respiratory disease other than COPD.21 For the purposes of 
this study, analysis of the first visit’s measurements was used. 
Therefore, in total 101 patients were included here instead of 
the 90 patients who completed all three visits. More details 
have been published elsewhere.21
Patient-reported outcomes
The questionnaires – CCQ, CAT, mMRC (study A), and 
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Questionnaire cutoff points in COPD
document were used.7–9 The SGRQ, the most widely used 
questionnaire in COPD research, was also administered.19
The CCQ is a ten-item questionnaire that consists of three 
domains: symptoms, functional status, and mental state.7 Total 
scores range from 0 to 6 (0= no impairment). The minimum 
clinically important difference (MCID) is 0.4.22 The CCQ cutoff 
point suggested by GOLD for symptomatic patients is $1,4,5 
and only recently it has been proposed that it may be 1–1.5.1,6
The CAT is an eight item one-dimensional questionnaire 
of health-status impairment in COPD. Total scores range 
from 0 to 40 (0= no impairment). The MCID is suggested 
to be approximately 2 points.23 The CAT cut point suggested 
by GOLD for symptomatic patients is $10.1,4–6
The mMRC is a one-dimensional tool assessing dyspnea 
during exercise in five levels. Several versions circulate. The 
mMRC ranges from 0 to 4, and is recommended by GOLD. 
The (original) mMRC ranges from 1 to 5 and has similar 
wording.9 To acquire compatible data, the study B scores 
were lowered by 1 point to calculate representative mMRC 
scores. The MCID is 1. The mMRC cutoff point suggested 
by GOLD for symptomatic patients is $2.1,4–6
The SGRQ is a self-administered questionnaire that 
measures health status in patients with chronic airflow limita-
tion. For this study, the 50-item version was used. The total 
score ranges from 0 (perfect health) to 100, and has three 
domains: symptoms, activity, and impact.19 The MCID is 4. 
The suggested SGRQ cutoff point for highly symptomatic 
patients is $25.6
statistical analysis
Data analysis was performed using SPSS 20 (IBM, Armonk, 
NY, USA). Both data sets were assessed for normal distribu-
tion. Patient characteristics between the studies were compared 
using χ2 tests, independent t-tests, or Mann–Whitney U-tests 
where appropriate. In both studies, correspondence was 
assessed between the recommended cutoff point of the SGRQ 
($25) and the cutoff points of the CCQ ($1), CAT ($10), 
and mMRC scale ($2), expressed in sensitivity and specificity 
using receiver-operating characteristic (ROC) curves.
To assess alternative and possibly superior cutoff points 
for the suggested SGRQ 25, we have used SGRQ cutoff 
points of 15–30 to split the data sets. The mean differences 
in the other questionnaires (CCQ, CAT) between the low 
and high SGRQ groups were then listed. The maximal 
differences in the CAT or CCQ were then used to create 
additional ROC curves.
To assess whether the areas under the curve (AUCs) were 
significantly different from one another, which would imply 
that one questionnaire was better able to discriminate between 
high and low symptoms than another, the differences between 

















where SE is standard error and r Pearson product-moment 
correlation.24
ethics approval
Study A was approved by the Ethik-Kommission der 
Bayerischen Landesärztekammer. Study B was approved by 
the local medical ethics committee of the University Hospital 
of Crete, Greece.
Results
Patient characteristics of data sets A and B are shown in 
Table 1. Patients in study A were significantly younger and 
consisted of more female patients. Patients in study B had 
significantly more pack-years. In general, health-status scores 
were higher in the pulmonary rehabilitation group (study A) 
than in the primary care group (study B). Mean baseline 
levels in study groups A and B for the recommended health-
status and dyspnea instruments were (respectively) 2.85 and 
1.52 (CCQ), 20.18 and 12.65 (CAT), and 50.13 and 35.24 
(SGRQ), while for the mMRC scale were 2.53 in group A 
and 0.85 in group B.
rOC analysis
The AUC of the CCQ was significantly higher than the 
AUC of the CAT in study A for both SGRQ cutoff points. 
In study B, the AUC of the CCQ was superior to the CAT 
only for cutoff point of 25 (Table 2). In addition, in study B 
the AUC of the CCQ was also superior to the mMRC scale 
for both cutoff points.
In study A, the proportions of sensitivity, specificity, and 
AUC for the cutoff point SGRQ $25 were (respectively) 
0.99, 0.43, and 0.96 for CCQ $1; 0.92, 0.48, and 0.89 for 
CAT $10; and 0.68, 0.91, and 0.91 for mMRC $2. In 
study B, these results were for the cutoff point SGRQ $25, 
and were (respectively) 0.87, 0.77, and 0.9 for CCQ $1; 
0.76, 0.73, and 0.82 for CAT $10; and 0.21, 1, and 0.81 for 
mMRC $2 (Table 3). The maximal difference of high versus 
low CCQ or CAT scores based on the changing SGRQ cutoff 
of 15–30 was 2.01 for the CCQ and 11.5 for the CAT, both 
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When the SGRQ cutoff point was adjusted to $20, the 
proportions of sensitivity, specificity, and AUC were (respec-
tively) 0.99, 0.73, and 0.99 for CCQ $1; 0.91, 0.73, and 0.94 
for CAT $10; and 0.66, 0.95 and 0.94 for mMRC $2. In 
study B, these results were 0.8, 0.89, and 0.89 for CCQ $1; 
0.69, 0.78, and 0.8 for CAT $10; and 0.18, 1, and 0.81 for 
mMRC $2. Visual results for the ROC analysis are demon-
strated in Figures 1–4. Overall, the percentage of symptomatic 
patients in the SGRQ cutoff-25 group amounted to 86.1%, 
while in the SGRQ cutoff-20 group this percentage was 
91.7%. These percentages differed significantly (P,0.001).
Discussion
This study, using data from two samples of populations with 
some different characteristics, showed that the suggested cut-
off point for the SGRQ ($25) did not appear to correspond 
well with the established cutoff points of both the CCQ and 
CAT, resulting in low specificity levels. This study examined 
whether an SGRQ cutoff point of $25, which was recently 
proposed as an equivalent to the CAT cutoff point of $10, 
could indeed be considered the gold standard.6,13 Next, this 
study investigated the criterion validity of the CCQ, CAT, 
and mMRC cutoff points in differentiating between high- and 
low-symptom groups using the suggested cut point of the 
SGRQ as the gold standard based on sensitivity and specificity 
analysis. The correspondence with the mMRC scale seemed 
satisfactory, though not optimal. An SGRQ threshold $20 
results in better sensitivity and specificity for the CCQ and 
CAT, as well as improved specificity for the mMRC scale.
The GOLD classification of patients according to the 
CCQ, CAT, or mMRC scale has already been proven to 
lead to a discrepancy in categorization, mainly between 
the health-status instruments and the dyspnea instrument 
(mMRC).10–16 This dissociation was also found in the ROC 
profiles in the current study. The crucial difference between 
25 versus 20 was primarily due to the patients from primary 
care (study B), as shown in Figures 1–4, meaning that more 
studies are needed to be able to draw safe conclusions.
The 2015 GOLD statement included a paragraph on the 
choice of cutoff points.6 Two arguments were forwarded 
to elect the SGRQ cutoff of 25: firstly, healthy individuals 
Table 1 Patient characteristics
Data set A (n=238) Data set B (n=101) P-value
age (years) 57.18±7.10 66.07±8.80 ,0.001
sex ,0.001
Female 87 (36.6) 9 (8.9)
Male 151 (63.4) 92 (91.1)
BMI (kg/m2) 26.96±6.49 28.33±5.34 0.061
smoking behavior
smoking (pack-years) 40.22±24.64 63.85±35.30 ,0.001
spirometry
FeV1, l 1.55±0.58 1.53±0.59 0.807
FeV1 % predicted 51.16±15.67 56.21±18.75 0.015
health status
mMrC scale 2.53±1.22 0.85±0.94 ,0.001
sgrQ total 50.13±17.99 35.24±17.41 ,0.001
CCQ total 2.85±1.19 1.52±0.94 ,0.001
CaT total 20.18±7.59 12.65±7.45 ,0.001
Note: Data expressed as means ± standard deviation or frequency (%).
Abbreviations: BMI, body mass index; CaT, COPD assessment Test; CCQ, Clinical COPD Questionnaire; FeV1, forced expiratory volume in 1 second; mMRC, modified 
Medical research Council; sgrQ, st george’s respiratory Questionnaire.
Table 2 Differences between two aUCs for the sgrQ cutoff 
points 20 and 25
Questionnaires AUCs P-value
SGRQ cut point 20
study a CCQ, CaT 0.986, 0.943 ,0.01*
CCQ, mMrC scale 0.986, 0.935 0.10
CaT, mMrC scale 0.943, 0.935 0.80
study B CCQ, CaT 0.894, 0.800 0.06
CCQ, mMrC scale 0.894, 0.811 0.04*
CaT, mMrC scale 0.800, 0.811 0.85
SGRQ cut point 25
study a CCQ, CaT 0.964, 0.885 ,0.001*
CCQ, mMrC scale 0.964, 0.912 0.07
CaT, mMrC scale 0.885, 0.912 0.46
study B CCQ, CaT 0.899, 0.822 0.04*
CCQ, mMrC scale 0.899, 0.809 0.03*
CaT, mMrC scale 0.822, 0.809 0.80
Note: *P,0.05.
Abbreviations: aUCs, areas under the curve; CaT, COPD assessment Test; 
CCQ, Clinical COPD Questionnaire; mMRC, modified Medical Research Council; 
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Questionnaire cutoff points in COPD
seldom score .25, while COPD patients often score .25; 
and secondly, in trials for long-acting bronchodilators, 26 is 
one standard deviation below the studies’ baseline SGRQ 
scores. Although the SGRQ was developed long before the 
CAT and CCQ, the CAT, CCQ, and mMRC scale were the 
first to be included in treatment guidelines and studies.4 Deter-
mining the cutoff for the SGRQ based on the differentiation 
between healthy subjects and COPD patients or on statistical 
grounds is thus less obvious than relating it to the CAT, CCQ, 
or mMRC scale cutoff points used in the guidelines.
Several comparisons have been reported. Recent research 
suggested a CAT score of ten correspondents with a CCQ 
score of 1.5.25 Mean CCQ and CAT scores were 2.9 and 
21.2, respectively, which corresponds with our rehabilitation 
cohort.25 Kim et al showed that an mMRC-scale score of 
2 corresponded to a mean CAT of 21 (standard deviation 8), 
Table 3 results from the rOC-curve analysis for the sgrQ cut points 20 and 25
























































































Notes: rOC results for mMrC 1.5 and 2.5 provided. since median =2, the average of both values was calculated.
Abbreviations: AUC, area under the curve; CAT, COPD Assessment Test; CCQ, Clinical COPD Questionnaire; CI, confidence interval; mMRC, modified Medical 
research Council; rOC, receiver-operating characteristic; sgrQ, st george’s respiratory Questionnaire.
Figure 1 rOC curves (study a) for sgrQ cut point $25.
Abbreviations: CaT, COPD assessment Test; CCQ, Clinical COPD Questionnaire; 
mMRC, modified Medical Research Council; ROC, receiver-operating characteristic; 












Figure 2 rOC curves (study B) for sgrQ cut point $25.
Abbreviations: CaT, COPD assessment Test; CCQ, Clinical COPD Questionnaire; 
mMRC, modified Medical Research Council; ROC, receiver-operating characteristic; 
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while an mMRC-scale score of 1 corresponded to a mean 
CAT score of 13 (standard deviation 6).16 On the other 
hand, Jones et al demonstrated that an mMRC-scale score of 
1 corresponded to a CAT score of 10.15 Han et al performed 
Figure 3 rOC curves (study a) for sgrQ cut point $20.
Abbreviations: CaT, COPD assessment Test; CCQ, Clinical COPD Questionnaire; 
mMRC, modified Medical Research Council; ROC, receiver-operating characteristic; 












Figure 4 rOC curves (study B) for sgrQ cut point $20.
Abbreviations: CaT, COPD assessment Test; CCQ, Clinical COPD Questionnaire; 
mMRC, modified Medical Research Council; ROC, receiver-operating characteristic; 












a study that defined categories using the mMRC scale (0–1 
versus $2) and the SGRQ ($25 versus ,25 as a surrogate 
for the CAT $10 versus ,10), and showed that the choice of 
symptom measure influenced category assignment.13 Formal 
testing of the AUCs resulted in superior performance of the 
CCQ compared to the CAT at both cutoff points. This sug-
gests that the CCQ is better in correctly categorizing low- and 
high-symptomatic COPD patients using the SGRQ as the 
gold standard, which is important for the interpretation of 
clinical trial results.
The discrepancy in patient classification between the 
CCQ, CAT, SGRQ, and mMRC scale may be explained by 
the differences in content: the CCQ has ten questions that 
can be divided into three domains measuring symptoms 
(dyspnea, cough, sputum) and mental (fear and depres-
sion due to respiratory symptoms) and functional status 
(limitations due to respiratory symptoms). The CAT has 
been designed as a one-dimensional tool to assess such 
parameters as cough, phlegm, chest tightness, breathlessness 
going up hills/stairs, activity limitation, sleep, energy, and 
confidence leaving home. Apart from symptoms, the SGRQ 
also assesses activities and impact of the disease similarly 
to the CCQ. Finally, the mMRC scale measures dyspnea 
due to exercise. In the original development studies of both 
the CCQ and CAT, their correlations with dyspnea were 
moderate.7,8 Although the CAT, SGRQ, and CCQ measure 
the same construct, due to differences in content it may be 
difficult to find cutoff points that allow the division of all 
patient populations in exactly the same groups. For example, 
patients with exercise limitations due to breathlessness but 
few other symptoms might score slightly higher on the CCQ 
than on the CAT, resulting in being classified symptomatic 
on the CCQ and not symptomatic on the CAT. Outcomes 
from questionnaires in daily clinical practice should not be 
regarded as carved in stone; they are indicators that should 
initiate a discussion between clinicians and patients. In the 
aforementioned example, the patient may be advised to spend 
some time each day exercising based on the results of the 
functional domain of the CCQ or on the one question about 
activity limitation of the CAT.
strengths and limitations
Some limitations of this study should be mentioned. The 
paper did not use symptoms as the gold standard, but instead 
defined symptomatic patients according to their score on other 
scales. The subjects in study A were selected to participate in 
a randomized controlled trial regarding rehabilitation. Usu-
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Questionnaire cutoff points in COPD
symptomatic and not the most appropriate population to study 
cutoff points for patients who are symptomatic or not. How-
ever, subjects in study B were selected largely from primary 
care, and may not have been subject to this selection bias. Sec-
ondly, we decided for the sake of clarity not to use follow-up 
data. Although follow-up data would clarify the importance of 
different cutoff values in clinical practice, the numbers were 
too small to draw conclusions. One of the strengths of this 
study is that it is the first real-life study to assess cutoff points 
for the CCQ, CAT, SGRQ, and mMRC scale.
Conclusion
In these two samples, the suggested cutoff point for the 
SGRQ ($25) did not appear to correspond well with the 
established cutoff points of either the CCQ or CAT, resulting 
in low specificity levels, while the correspondence with the 
mMRC scale seemed satisfactory. An SGRQ threshold $20 
showed better sensitivity and specificity for the CCQ and 
CAT, as well as improved specificity for the mMRC scale. 
Based on our findings, we recommend the GOLD committee 
reconsider its cutoff point for the SGRQ.
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